| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
11,608 |
10,843 |
$2.85M |
| 90834 |
Psychotherapy, 45 minutes with patient |
4,354 |
2,718 |
$1.15M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
3,430 |
3,305 |
$908K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
5,712 |
5,462 |
$836K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,578 |
3,270 |
$616K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,664 |
3,349 |
$551K |
| 36415 |
Collection of venous blood by venipuncture |
7,992 |
6,364 |
$486K |
| 90832 |
Psychotherapy, 30 minutes with patient |
1,735 |
1,445 |
$410K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
862 |
781 |
$403K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
2,517 |
774 |
$365K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
2,719 |
2,511 |
$346K |
| 80053 |
Comprehensive metabolic panel |
10,597 |
9,609 |
$297K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,129 |
1,907 |
$293K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,078 |
1,965 |
$282K |
| 99215 |
Prolong outpt/office vis |
1,128 |
1,047 |
$272K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,754 |
1,716 |
$266K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
4,337 |
3,903 |
$197K |
| 87486 |
|
1,107 |
1,071 |
$169K |
| H0038 |
Self-help/peer services, per 15 minutes |
1,660 |
717 |
$160K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
528 |
506 |
$147K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
441 |
420 |
$130K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
1,464 |
394 |
$121K |
| G0397 |
Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and intervention, greater than 30 minutes |
852 |
590 |
$110K |
| 90791 |
Psychiatric diagnostic evaluation |
320 |
299 |
$99K |
| 70450 |
Computed tomography, head or brain; without contrast material |
305 |
296 |
$93K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
2,696 |
2,677 |
$89K |
| 81025 |
|
1,275 |
1,227 |
$89K |
| 90837 |
Psychotherapy, 53 minutes with patient |
596 |
400 |
$85K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
1,603 |
1,521 |
$76K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
559 |
550 |
$70K |
| G0396 |
Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes |
450 |
323 |
$41K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
591 |
571 |
$41K |
| 84443 |
Thyroid stimulating hormone (TSH) |
4,916 |
4,819 |
$40K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
151 |
135 |
$37K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
708 |
691 |
$36K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,362 |
1,263 |
$35K |
| 99205 |
Prolong outpt/office vis |
117 |
116 |
$30K |
| 80061 |
Lipid panel |
3,973 |
3,929 |
$29K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
1,478 |
1,066 |
$29K |
| H0001 |
Alcohol and/or drug assessment |
215 |
153 |
$29K |
| 84439 |
|
3,004 |
2,959 |
$24K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
10,812 |
9,797 |
$23K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,644 |
2,627 |
$23K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
535 |
528 |
$21K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
595 |
536 |
$21K |
| 87581 |
|
1,107 |
1,071 |
$20K |
| 97161 |
|
112 |
112 |
$15K |
| 82607 |
|
1,323 |
1,316 |
$15K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
262 |
262 |
$15K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
522 |
515 |
$10K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
24 |
24 |
$10K |
| 71046 |
Radiologic examination, chest; 2 views |
1,771 |
1,718 |
$9K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,931 |
1,834 |
$9K |
| 82728 |
|
663 |
650 |
$8K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
104 |
103 |
$7K |
| 83735 |
|
1,858 |
1,666 |
$6K |
| 86140 |
|
1,051 |
957 |
$6K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
2,085 |
1,943 |
$6K |
| 81001 |
|
2,253 |
2,155 |
$5K |
| 83880 |
|
144 |
131 |
$4K |
| 90836 |
|
15 |
14 |
$4K |
| 85610 |
|
1,359 |
953 |
$4K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
236 |
232 |
$4K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
259 |
259 |
$4K |
| 90686 |
|
123 |
122 |
$3K |
| 83655 |
|
213 |
212 |
$3K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
25 |
25 |
$3K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
720 |
691 |
$3K |
| 81015 |
|
2,477 |
2,308 |
$3K |
| 87186 |
|
811 |
763 |
$3K |
| 83540 |
|
565 |
547 |
$3K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
157 |
156 |
$3K |
| 84481 |
|
294 |
294 |
$2K |
| 82570 |
|
536 |
530 |
$2K |
| 83550 |
|
508 |
494 |
$2K |
| 90688 |
|
13 |
13 |
$2K |
| 82043 |
|
474 |
471 |
$2K |
| 84100 |
|
485 |
455 |
$2K |
| 97162 |
|
13 |
12 |
$2K |
| 88142 |
|
74 |
73 |
$2K |
| 71045 |
Radiologic examination, chest; single view |
570 |
532 |
$2K |
| 87077 |
|
361 |
332 |
$2K |
| 86618 |
|
95 |
93 |
$2K |
| 82746 |
|
163 |
162 |
$1K |
| 86803 |
|
178 |
176 |
$1K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
17 |
17 |
$1K |
| 99443 |
|
16 |
14 |
$1K |
| 84702 |
|
148 |
123 |
$1K |
| 87340 |
|
118 |
117 |
$1K |
| 83690 |
|
1,918 |
1,772 |
$1K |
| 81003 |
|
1,404 |
1,350 |
$991.93 |
| 85652 |
|
696 |
654 |
$959.42 |
| 85651 |
|
527 |
504 |
$905.79 |
| 99051 |
|
70 |
66 |
$872.07 |
| 99442 |
|
14 |
14 |
$859.82 |
| 85730 |
|
483 |
462 |
$775.96 |
| 90715 |
|
26 |
26 |
$704.64 |
| 76830 |
Ultrasound, transvaginal |
24 |
24 |
$690.79 |
| 84207 |
|
24 |
24 |
$646.30 |
| 86780 |
|
66 |
66 |
$597.31 |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
170 |
159 |
$508.94 |
| 87081 |
|
189 |
181 |
$492.94 |
| 84153 |
|
26 |
26 |
$452.10 |
| 84484 |
|
1,331 |
972 |
$358.55 |
| 73630 |
|
96 |
93 |
$351.50 |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
94 |
52 |
$348.98 |
| 82150 |
|
504 |
470 |
$345.32 |
| 84480 |
|
43 |
43 |
$251.20 |
| 86850 |
|
25 |
25 |
$236.46 |
| 80320 |
|
80 |
77 |
$235.00 |
| 85014 |
|
158 |
154 |
$222.82 |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
14 |
13 |
$210.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
120 |
116 |
$202.30 |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
29 |
28 |
$201.81 |
| 74018 |
|
44 |
43 |
$180.84 |
| 86901 |
|
25 |
24 |
$176.70 |
| 82550 |
|
45 |
44 |
$174.59 |
| 86900 |
|
24 |
24 |
$156.72 |
| 85027 |
|
70 |
69 |
$154.58 |
| 82747 |
|
13 |
13 |
$151.56 |
| G0008 |
Administration of influenza virus vaccine |
14 |
14 |
$146.96 |
| 85379 |
|
76 |
73 |
$123.06 |
| 73610 |
|
56 |
55 |
$115.00 |
| 84703 |
|
239 |
229 |
$102.63 |
| 73030 |
|
12 |
12 |
$99.72 |
| 87070 |
|
13 |
13 |
$81.50 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
805 |
718 |
$64.47 |
| 84436 |
|
12 |
12 |
$61.98 |
| 80305 |
|
161 |
147 |
$61.50 |
| 86038 |
|
14 |
14 |
$57.20 |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,384 |
1,253 |
$56.10 |
| A9270 |
Non-covered item or service |
2,099 |
1,863 |
$54.68 |
| 83605 |
|
227 |
191 |
$54.40 |
| 87040 |
|
24 |
13 |
$17.99 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
598 |
538 |
$15.20 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,387 |
850 |
$4.12 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
572 |
516 |
$2.03 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
72 |
70 |
$0.11 |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
436 |
424 |
$0.00 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
49 |
38 |
$0.00 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
14 |
14 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
18 |
17 |
$0.00 |